Funding Opportunity: MaRS Procurement by Co-Design Program

Deadline for Submission October 13, 2017, 5PM EST

Innovation Partnership: Procurement by Co-Design is a unique program that offers healthcare-service providers something rare: the opportunity to participate in the development of innovative solutions before procuring them. In turn, technology and service innovators with scalable business models can gain unprecedented access to end users and validate use cases to remain competitive.

Analysis: Update to Ontario's Health Sector Payment Transparency Act, By Norton Rose Fulbright

The Ontario Minister of Health and Long-Term Care (the “Minister”) introduced Bill 160:
An Act to amend, repeal and enact various Acts in the interest of strengthening quality and
accountability for patients on September 27, 2017. One of the new enactments is the Health Sector Payment Transparency Act (the “Act”) which will require the reporting of information about financial relationships in the Ontario healthcare system.

Synaptive Medical Appoints Peter Wehrly as Ceo

TORONTO, ON (October 5, 2017) – Synaptive Medical, a leading Canadian medical device and technology company, announced today the appointment of veteran healthcare executive and current chairman of the board Peter Wehrly as chief executive officer. Cameron Piron will continue to serve as president and assume the new role of chief strategy officer.

Funding Announcement: Ontario Genomics' Genomic Applications Partnership Program (GAPP)

Ontario Genomics iannounced that Round 10 of their Genome Canada’s Genomic Applications Partnership Program is now open.

The Genomic Applications Partnership Program (GAPP) funds public-private research collaborations focused on developing genomics-derived technologies that address opportunities and challenges identified by industry, government, not-for-profits or other “Receptors” of genomics knowledge and tools.

EOI forms are due to Ontario Genomics on November 13th, 2017 at 9 am ET.

Information and Application

Canadian Space Agency Information Session, Oct 26 2017 In Toronto

The Canadian Space Agency (CSA), in partnership with the National Research Council of Canada's Industrial Research Assistance Program (IRAP), wishes to engage the biomedical, health and performance communities as well as space stakeholders to help identify potential Canadian health and biomedical roles in human deep space missions, and explore new ways to collaborate to improve the innovation process in both space and terrestrial health.